Moderna
MRNA
#1830
Rank
NZ$18.73 B
Marketcap
NZ$47.95
Share price
8.67%
Change (1 day)
-34.32%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$21.00 Billion

According to Moderna 's latest financial reports the company's total assets are NZ$21.00 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$25.07 B-13.94%
2023-12-31NZ$29.13 B-28.46%
2022-12-31NZ$40.72 B12.77%
2021-12-31NZ$36.11 B255.18%
2020-12-31NZ$10.16 B330.87%
2019-12-31NZ$2.36 B-19.32%
2018-12-31NZ$2.92 B91.56%
2017-12-31NZ$1.52 B-25.36%
2016-12-31NZ$2.04 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.12 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 967.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$12.85 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.39 B-60.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$185.71 B 784.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
NZ$2.38 B-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.76 B 1,488.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA